Molecular targets for endogenous glial cell line-derived neurotrophic factor modulation in striatal parvalbumin interneurons

Administration of recombinant glial cell line-derived neurotrophic factor into the putamen has been tested in preclinical and clinical studies to evaluate its neuroprotective effects on the progressive dopaminergic neuronal degeneration that characterizes Parkinson’s disease. However, intracerebral...

Descripción completa

Detalles Bibliográficos
Autores principales: Enterría-Morales, Daniel, del Rey, Natalia López-González, Blesa, Javier, López-López, Ivette, Gallet, Sarah, Prévot, Vincent, López-Barneo, José, d’Anglemont de Tassigny, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472905/
https://www.ncbi.nlm.nih.gov/pubmed/32954345
http://dx.doi.org/10.1093/braincomms/fcaa105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472905/
https://www.ncbi.nlm.nih.gov/pubmed/32954345
http://dx.doi.org/10.1093/braincomms/fcaa105

Ejemplares similares